Flawless Pharma Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
- Paid Up Capital ₹ 6.39 M
- Company Age 14 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 2563.15%
- Profit Growth 23454.35%
- Ebitda 22238.35%
- Net Worth 1325303.85%
- Total Assets 4030.85%
About Flawless Pharma
Flawless Pharma Private Limited (FPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 27 October 2010 and has a history of 14 years and three months. Its registered office is in Mumbai, Maharashtra, India.
The Corporate was formerly known as Flawless Exim Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 6.39 M, as per Ministry of Corporate Affairs (MCA) records.
Sujeetkumar Singh and Gaurav Singh serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U74110MH2010PTC209508
-
Company No.
209508
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
27 Oct 2010
-
Date of AGM
22 Aug 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Flawless Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sujeetkumar Singh
|
Director | 02-Jan-2023 | Current |
|
Gaurav Singh
|
Director | 01-Sep-2021 | Current |
Financial Performance of Flawless Pharma.
Flawless Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 2563.15% increase. The company also saw a substantial improvement in profitability, with a 23454.35% increase in profit. The company's net worth Soared by an impressive increase of 1325303.85%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Flawless Pharma?
In 2023, Flawless Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Forever Cine Productions Private LimitedSujeetkumar Singh is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Flawless Pharma?
Unlock and access historical data on people associated with Flawless Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Flawless Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Flawless Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
